Severity and depression can impact quality of life in patients with myasthenia gravis
- 1 October 2019
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 61 (1) , 69-73
Abstract
Background: The revised 15‐item Myasthenia Gravis (MG) Quality of Life Questionnaire (MGQoL15R) is a validated scale of quality of life in patients with MG. We aimed to study the factors causing the variability within the Arabic version of the MGQoL15R (MGQoL15R‐A).Method: A standardized questionnaire was completed by 118 patients. Correlations and hierarchical regression analyses were used to assess the contribution of sociodemographic variables, clinical factors, Patient Health Questionnaire‐9 (PHQ9‐A), and Generalized Anxiety Disorder‐7 (GAD7‐A) to the variability in the MGQoL15R‐A.Results: The MGQoL15R‐A was highly correlated with PHQ9‐A (r = 0.76), and moderately correlated with GAD7‐A (r = 0.52). Clinical factors and PHQ9‐A independently explained 30.4% and 34.5% of the variability, respectively. Among the clinical factors, uncontrolled MG status, relapse within the past year, and a higher number of current MG therapies were significantly associated with a higher MGQoL15R‐A score.Conclusions: MG severity and depressive symptoms (measured by PHQ9‐A) can affect the MGQoL15R‐A score.Keywords
Funding Information
- Deanship of Scientific Research, King Saud University
This publication has 15 references indexed in Scilit:
- Muscle strength and psychiatric symptoms influence health-related quality of life in patients with myasthenia gravisJournal of Clinical Neuroscience, 2018
- Quality of life in patients with MuSK positive myasthenia gravisActa Neurologica Belgica, 2018
- Translation and validation of the arabic version of the revised 15‐item myasthenia gravis quality‐of‐life questionnaireMuscle & Nerve, 2017
- International clinimetric evaluation of the MG‐QOL15, resulting in slight revision and subsequent validation of the MG‐QOL15rMuscle & Nerve, 2016
- Adaptation and initial validation of the Patient Health Questionnaire – 9 (PHQ-9) and the Generalized Anxiety Disorder – 7 Questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient samplePsychiatry Research, 2016
- Health‐related quality‐of‐life and treatment targets in myasthenia gravisMuscle & Nerve, 2014
- The MG‐QOL15 Japanese version: Validation and associations with clinical factorsMuscle & Nerve, 2012
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- Screening for Somatization and Depression in Saudi Arabia: A Validation Study of the Phq in Primary CareThe International Journal of Psychiatry in Medicine, 2002
- The PHQ-9Journal of General Internal Medicine, 2001